Greenleaf Trust Has $438,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Greenleaf Trust increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 30.2% during the fourth quarter, HoldingsChannel reports. The fund owned 16,788 shares of the pharmacy operator’s stock after buying an additional 3,898 shares during the period. Greenleaf Trust’s holdings in Walgreens Boots Alliance were worth $438,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in WBA. EverSource Wealth Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the period. Highlander Capital Management LLC acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at $26,000. Venturi Wealth Management LLC increased its stake in Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC increased its stake in Walgreens Boots Alliance by 2,314.5% in the 3rd quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at $30,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. Bank of America decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. HSBC reissued a “reduce” rating and issued a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a research report on Wednesday, April 3rd. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $24.36.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $18.05 on Wednesday. The company has a market capitalization of $15.57 billion, a price-to-earnings ratio of -2.58, a PEG ratio of 1.13 and a beta of 0.73. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company has a 50-day simple moving average of $20.26 and a 200 day simple moving average of $21.86. Walgreens Boots Alliance, Inc. has a 52 week low of $17.51 and a 52 week high of $35.54.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.16 EPS. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares in the company, valued at $54,150. The disclosure for this purchase can be found here. Insiders acquired 13,456 shares of company stock valued at $270,423 in the last quarter. Company insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.